Avishay Ben Moscovici - 18 Mar 2026 Form 3 Insider Report for Innoviz Technologies Ltd. (INVZ)

Role
Chief R&D Officer
Signature
/s/ Dafna Raz - Attorney-in-Fact
Issuer symbol
INVZ
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 18:38:58 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Moscovici Avishay Ben Chief R&D Officer C/O INNOVIZ TECHNOLOGIES LTD., 5 URI ARIAV STREET, BUILDING C, ROSH HA'AIN, ISRAEL /s/ Dafna Raz - Attorney-in-Fact 18 Mar 2026 0002030150

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INVZ Ordinary Shares 330,665 18 Mar 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 65,322 $0.5695 Direct F3
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 31,607 $1.14 Direct F3
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 39,504 $9.92 Direct F3
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 60,667 $11.50 Direct F3
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 24,064 $5.23 Direct F4
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 30,144 $4.03 Direct F5
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 48,480 $0.7500 Direct F6
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 53,120 $1.61 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 172,296 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 4,010 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 12,810 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 14,636 RSUs granted February 27, 2024, with 2,684 vesting quarterly through 2027 and 11,952 vesting quarterly through 2028; (d) 28,280 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 14,928 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 49,584 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029; and (g) 48,048 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.
F2 No exercise price is applicable.
F3 Immediately exercisable.
F4 Share options granted on August 9, 2022. Includes 21,056 vested options, and 3,008 unvested options, which shall vest in equal quarterly installments through 2026, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
F5 Share options granted on August 1, 2023. Includes 18,840 vested options, and 11,304 unvested options, which shall vest in equal quarterly installments through 2027, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
F6 Share options granted on August 20, 2024. Includes 18,180 vested options, and 30,300 unvested options, which shall vest in equal quarterly installments through 2028, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
F7 Share options granted on August 5, 2025. Includes no vested options, and 53,120 unvested options, with one-fourth of the options vesting on August 5, 2026, and the remaining shall vest in equal quarterly installments through 2029, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

Remarks:

[Exhibit 24 - Power of Attorney.]